𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome : A Report From the Children's Oncology Group

✍ Scribed by Susan E. Puumala; Julie A. Ross; Andrew F. Olshan; Leslie L. Robison; Franklin O. Smith; Logan G. Spector


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
98 KB
Volume
110
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND.

Children with Down syndrome (DS) have from 10 to 20 times the risk of developing acute leukemia than the general pediatric population. There is mixed evidence for associations between reproductive history or infertility and acute leukemia among children without DS.

METHODS.

The authors conducted a case‐control study of acute leukemia among children with DS to investigate possible risk factors in this population. From 1997 to 2002, 158 children aged <20 years with DS who had a diagnosis of acute leukemia (97 children with acute lymphoblastic leukemia [ALL] and 61 children with acute myeloid leukemia [AML]) were enrolled at Children's Oncology Group (COG) institutions. Controls with DS (n = 173) were selected from the cases' primary care clinic and frequency matched to cases on age. Telephone interviews were conducted with mothers of cases and controls assessing reproductive history, infertility, and infertility treatment.

RESULTS.

Null results were observed overall and by subtype for reproductive factors, including previous pregnancy outcomes and contraceptive use, and for most infertility outcomes. There was an increased risk of AML among children with DS whose parents had ever tried for β‰₯1 year to become pregnant (odds ratio [OR], 2.22; 95% confidence interval [95% CI], 1.14–4.33). A 1‐year increase in maternal age also was associated with AML (OR, 1.06; 95% CI, 1.01–1.12).

CONCLUSIONS.

Although the questionnaire was limited in this area, the results suggested that the risk for AML may be raised in children with DS because of infertility. In that the risk of infertility, along with having a child with DS, increase with age, these results warrant more research. Cancer 2007. Β© 2007 American Cancer Society.


πŸ“œ SIMILAR VOLUMES


Clinical characteristics and treatment o
✍ Abdelsalam H. Ragab; Aly Abdel-Mageed; Jonathan J. Shuster; Lawrence S. Frankel; πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 683 KB

Of 2947 children with acute lymphocytic leukemia (ALL), treated during three consecutive studies of the Pediatric Oncology Group (1974-1986), 52 (1.8%) had Down's Syndrome (DS). Comparison of clinical and laboratory characteristics showed no significant differences in leukocyte count, racial distrib

Improvement in CNS protective treatment
✍ Tsurusawa, Masahito; Katano, Naoyuki; Yamamoto, Yoshifumi; Hirota, Takahisa; Koi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 3 views

Background. Prevention of central nervous system (CNS) leukemia by early introduction of therapy to this sanctuary site is an essential component of modern treatment strategy for acute lymphoblastic leukemia (ALL). However, the optimal form of preventive CNS therapy remains debatable. Procedure. To

Successful reinduction therapy with amsa
✍ Linda P. Miller; Allan F. Pyesmany; Lawrence J. Wolff; Paul C. J. Rogers; Stuart πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 644 KB

Amsacrine (AMSA) and cyclocytidine were studied as retrieval therapy in 122 pediatric patients with acute nonlymphoblastic leukemia (ANLL). Patients either failed to achieve sustained initial remissions or were in relapse. Induction therapy consisted of intravenous (IV) AMSA (75 mg/mz) from days 1 t